Amy M. Winslow — Executive Vice President at Meridian Bioscience

Ms. Amy M. Winslow has been President at Magellan Diagnostics, Inc. since March 2016 and served as its Chief Executive Officer of Magellan Diagnostics since March 2016. Ms. Winslow has been an Executive Vice President of Meridian Bioscience, Inc since March 2016. Before joining Magellan in 2011, she founded and led MW Advisory, a strategy and marketing consulting firm. She served as Vice President of Marketing at Athena Diagnostics, Inc. for five years and was a Director of E-Commerce. She was employed by Athena Diagnostics, Inc. since 1999. From 1995 to 1997, Ms. Winslow was Marketing Manager of Primedica, Inc., a division of Genzyme Transgenics Corporation. Prior to 1995, Ms. Winslow was Product Manager in the USCI and Bard Electrophysiology Divisions of C.R. Bard, Inc., where she was responsible for their line of diagnostic cardiac electrophysiology catheters. She is a life sciences executive with two decades of experience in diagnostics, medical devices and pharmaceutical services. She was named by Mass High Tech as one of the '2013 Women to Watch' which recognizes women in technology and life sciences who are go-getters, hardworking, inspirational and motivational to their peers. Ms. Winslow holds a Bachelor of Arts degree in Biology from Brown University and a Master in Business Administration degree from the Harvard Business School.